Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
KRISHGEN BIOSYSTEMS Immunoassay for the estimation of Pembrolizumab in serum and plasma. Can be used for generics and biosimilar mAb PK studies. Assay Range: 10 - 640 ng/ml; Sensitivity: 8.25 ng/ml.
Supplier: KRISHGEN BIOSYSTEMS KBI1084
Pack Size: 1 x 96 wells. Background: Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, and cervical cancer. It is an immune checkpoint inhibitor against PD-L1, inhibiting lymphocytes' PD-1 receptors, blocking the ligands that would deactivate it and prevent an immune response. It is on the World Health Organization's List of Essential Medicines. This mAb-based Pembrolizumab ELISA accurately quantifies pembrolizumab and biosimilars in human samples. If you are looking to use animal samples, please contact us. ELISA Features include a pre-coated plate with break-apart wells, standardisation and Lot to Lot Consistency with Precision CV <15%.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?